FDA to Ban JUUL E-Cigarettes Over Youth Appeal

Jun.24.2022
The FDA prohibits JUUL e-cigarettes due to concerns about their impact on youth vaping. Nicotine is highly addictive and dangerous for teens.

The US Food and Drug Administration (FDA) announced today that it will ban the sale of JUUL e-cigarettes, citing the company's significant role in the popularity of youth e-cigarette use. Critics argue that JUUL's aggressive marketing tactics have led more teenagers to take up vaping. Public health experts warn that e-cigarettes are unsafe for youth, children, and young adults, as they contain nicotine, a highly addictive substance. Studies have also shown that exposure to nicotine during adolescence can lead to persistent behavioral problems, higher anxiety rates, and impulse control issues.

 

According to Adnan Hyder, Director of the Health and Business Decision-making Center at George Washington University and Senior Associate Dean for Public Health at the GW Milken Institute School of Public Health, the e-cigarette industry is taking advantage of the vulnerability of young people and exposing them to health risks. Hyder observed that the industry is using tactics commonly used by the tobacco industry, such as attacking regulations, promoting controversial evidence, promoting distrust, and utilizing marketing strategies like social media and advertising. He welcomed the FDA's decision and hopes that more regulations and restrictions on nicotine and tobacco products will follow.

 

Nino Paichadze, the Deputy Director and Expert on Health Business Determinants at the center states: "Electronic cigarettes are a rapidly emerging and diversified product category, particularly appealing to young adults and teens. As of 2021, over two million American middle and high school students reported currently using e-cigarettes. JUUL is just one of many e-cigarettes that contain high levels of nicotine, which is harmful to the developing brains of teens and can lead to numerous adverse health conditions. The company has been strategically marketing their products, taking advantage of the innocence and independence of young people. Given that young adults and teens are a crucial stage in human development, and considering the alarming statistics on e-cigarette use among American youth, the FDA's decision is both timely and necessary. This is a major victory for public health today!

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Newly published patent filings indicate that China Tobacco Hubei Industrial Co., Ltd., a subsidiary of China National Tobacco Corporation (CNTC), is exploring nicotine pouch technologies capable of releasing gas during oral use. The designs include carbon-dioxide microcapsules that burst in the mouth and effervescent systems that generate gas through chemical reactions with saliva, suggesting efforts to introduce new sensory dynamics into modern oral nicotine products.
News
Mar.04
Russia proposes extending voluntary labeling pilot for reusable e-cigarettes to Aug. 31, 2026
Russia proposes extending voluntary labeling pilot for reusable e-cigarettes to Aug. 31, 2026
Russia’s Ministry of Industry and Trade has proposed extending a voluntary labeling pilot covering reusable e-cigarettes and similar personal electric vaporizing devices until August 31, 2026. A draft government decree has been published on the unified portal for posting drafts of normative legal acts.
Jan.22 by 2FIRSTS.ai
Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Azerbaijan moves to fine and confiscate e-cigarettes across supply chain; full ban expected April 1, 2026
Azerbaijan moves to fine and confiscate e-cigarettes across supply chain; full ban expected April 1, 2026
Azerbaijan is considering administrative penalties for the use, import, export, production, wholesale and retail sale, and storage for sale of e-cigarettes, including confiscation of products. The proposed amendments were discussed at a parliamentary committee meeting. The draft sets fine ranges for individuals, officials, and legal entities, and introduces a separate fine for vaping in prohibited places and public areas.
Feb.27 by 2FIRSTS.ai
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03